Open AccessIncidence, Patient Characteristics, Mode of Drug Delivery, and Outcomes of Septic Shock Patients Treated With Vasopressors in the Arise Trial
Author(s) -
Andrew Udy,
Mark Finnis,
Daryl Jones,
Anthony Delaney,
Stephen Macdonald,
Rinaldo Bellomo,
Sandra Peake
Publication year - 2019
Publication title -
shock
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.095
H-Index - 117
eISSN - 1540-0514
pISSN - 1073-2322
DOI - 10.1097/shk.0000000000001281
Subject(s) - medicine , interquartile range , septic shock , confidence interval , emergency department , hazard ratio , sepsis , odds ratio , incidence (geometry) , anesthesia , psychiatry , physics , optics
To describe the utilization of vasopressors (VP) in patients enrolled in the Australasian Resuscitation In Sepsis Evaluation (ARISE) trial, and to explore the association between time to VP and 90-day mortality.